Compare AVXL & WTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AVXL | WTI |
|---|---|---|
| Founded | 2004 | 1983 |
| Country | United States | United States |
| Employees | N/A | 400 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 430.9M | 446.3M |
| IPO Year | 2013 | 2004 |
| Metric | AVXL | WTI |
|---|---|---|
| Price | $4.19 | $3.03 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $22.00 | N/A |
| AVG Volume (30 Days) | 826.5K | ★ 7.9M |
| Earning Date | 02-09-2026 | 03-16-2026 |
| Dividend Yield | N/A | ★ 1.33% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $487,096,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $0.73 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.86 | $1.09 |
| 52 Week High | $13.99 | $3.82 |
| Indicator | AVXL | WTI |
|---|---|---|
| Relative Strength Index (RSI) | 39.48 | 55.85 |
| Support Level | $3.60 | $1.75 |
| Resistance Level | $5.27 | $3.82 |
| Average True Range (ATR) | 0.27 | 0.34 |
| MACD | -0.04 | -0.02 |
| Stochastic Oscillator | 11.20 | 39.62 |
Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.
W&T Offshore Inc is an oil and gas exploration and production company. The company's exploration operations are focused in the Gulf of Mexico, where it drills for oil and gas. The company engages in both deepwater drilling and shallow-water shelf drilling. W&T Offshore extracts crude oil, natural gas, and natural gas liquids, which are then sold directly at the wellhead. Overall, crude oil accounts for the majority of company's revenue, with natural gas accounting for a much smaller portion.